The Current Use of Proton-Pump Inhibitor Therapy in Clinical GI Practice.
作者信息
Katz Philip O
机构信息
Chair, Division of Gastroenterology Albert Einstein Medical Center Philadelphia, Penn.
出版信息
Gastroenterol Hepatol (N Y). 2006 Dec;2(12):883-885.
Abstract
摘要
相似文献
1
The Current Use of Proton-Pump Inhibitor Therapy in Clinical GI Practice.
Gastroenterol Hepatol (N Y). 2006 Dec;2(12):883-885.
2
Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Aliment Pharmacol Ther. 1999 Apr;13(4):489-96. doi: 10.1046/j.1365-2036.1999.00504.x.
3
Lack of proton pump inhibitor trial prior to commencing therapy for eosinophilic esophagitis is common in the community.
Dis Esophagus. 2018 May 1;31(5). doi: 10.1093/dote/dox143.
4
[Proton pump inhibitors when using clopidogrel: balance between necessity and disadvantages].
Ned Tijdschr Geneeskd. 2019 May 24;163:D3363.
5
A COX-2-specific inhibitor plus a proton-pump inhibitor: is this a reasonable approach to reduction in NSAIDs' GI toxicity?
Am J Gastroenterol. 2006 Apr;101(4):711-3. doi: 10.1111/j.1572-0241.2006.00508.x.
6
Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice?
Dis Esophagus. 2018 Dec 1;31(12). doi: 10.1093/dote/doy042.
7
Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed.
Crit Pathw Cardiol. 2007 Dec;6(4):169-72. doi: 10.1097/HPC.0b013e318159921e.
8
Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Clin Ther. 2010 Apr;32(4):667-77. doi: 10.1016/j.clinthera.2010.04.009.
9
Chronic proton pump inhibitor therapy and the risk of colorectal cancer.
Gastroenterology. 2007 Sep;133(3):748-54. doi: 10.1053/j.gastro.2007.06.022. Epub 2007 Jun 20.
10
Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy.
Aliment Pharmacol Ther. 2004 Jan 15;19(2):197-208. doi: 10.1111/j.0269-2813.2004.01834.x.
本文引用的文献
1
Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure.
Aliment Pharmacol Ther. 2005 Dec;22 Suppl 3:31-8. doi: 10.1111/j.1365-2036.2005.02712.x.
2
Effectiveness of proton pump inhibitors: beyond cost.
Rev Gastroenterol Disord. 2004;4 Suppl 4:S8-S15.
3
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
Am J Gastroenterol. 2003 Dec;98(12):2616-20. doi: 10.1111/j.1572-0241.2003.08783.x.
4
Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
Best Pract Res Clin Gastroenterol. 2001 Jun;15(3):371-84. doi: 10.1053/bega.2001.0185.
Zotero 插件